MFDS — authorised 16 February 2001
- Marketing authorisation holder: NOVARTIS
- Status: likely_approved
🇰🇷 Foradil in South Korea
MFDS authorised Foradil on 16 February 2001
Marketing authorisation
Foradil in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Cardiovascular approved in South Korea
Frequently asked questions
Is Foradil approved in South Korea?
Yes. MFDS authorised it on 16 February 2001.
Who is the marketing authorisation holder for Foradil in South Korea?
NOVARTIS holds the South Korean marketing authorisation.